Professor Bob Djavan, MD, PhD, is an internationally recognised consultant urologist and urological surgeon with more than 30 years of experience in clinical practice, academic medicine and research.
He is Head of the Urology Centre at Rudolfinerhaus Hospital in Vienna, Austria, and holds professorial affiliations with the Medical University of Vienna and New York University (NYU).
His expertise focuses on prostate cancer, urological oncology, minimally invasive surgery and the diagnosis and treatment of prostate conditions. Throughout his career, Professor Djavan has combined specialist patient care with research, university teaching and international medical collaboration.
Professor Bob Djavan has built an extensive international career dedicated to advancing the diagnosis and treatment of urological conditions, particularly prostate cancer and diseases affecting the urinary system.
After completing his medical education at the Medical University of Vienna, he undertook specialist training in urology and gained further clinical experience at internationally respected institutions, including the University of Texas Southwestern Medical Center in Dallas and the Brady Urological Institute at Johns Hopkins School of Medicine in Baltimore.
He obtained specialist certification in urology in 1999 and subsequently developed a distinguished career spanning Europe, the United States and the Middle East.
Professor Djavan has held senior clinical and academic appointments at the Medical University of Vienna and New York University. His previous responsibilities in New York included leadership roles in urological research, prostate cancer care and minimally invasive treatment programmes.
At Rudolfinerhaus Hospital in Vienna, he leads the Urology Centre, where specialist diagnosis, contemporary surgical techniques and evidence-based treatment planning form important parts of clinical practice.
Alongside his work in Austria, Professor Djavan has been involved in international medical initiatives, including leadership of the GULF Uro-oncology Center in Bahrain.
His professional interests extend beyond individual patient care. For decades, he has contributed to medical education, scientific research and the development of international clinical cooperation, helping to connect specialists and research institutions across different healthcare systems.
Professor Djavan’s principal areas of expertise include prostate cancer diagnosis and treatment, urological oncology, benign prostatic enlargement and minimally invasive urological surgery.
His wider clinical practice also encompasses conditions affecting the kidneys, bladder and testicles, as well as urinary incontinence and erectile dysfunction.
Throughout his career, he has been involved in research and clinical developments intended to improve diagnostic precision, evaluate treatment options and support appropriate, individualised management of complex urological conditions.
In addition to his clinical responsibilities, Professor Djavan has maintained a prominent role in international urological research and medical education.
He has authored or contributed to more than 250 scientific articles and book chapters covering prostate disease, urological oncology, diagnostic methods and surgical treatment.
His research has included work on prostate cancer detection, diagnostic prediction models and techniques associated with prostate surgery. He also had contributions to the development of the Vienna Nomogram and other prostate-related clinical prediction tools.
Professor Djavan has served on editorial boards and as a scientific reviewer for international medical journals. He has also participated in professional education programmes, international congresses and visiting professorships throughout Europe, North America, Asia and the Middle East.
His contribution to international academic cooperation includes his appointment as Chair of the Committee for International Relations at the Vienna School of Clinical Research, Public Health and Medical Education.
Professor Djavan has received numerous professional awards and distinctions recognising his work in urology, medical research and international education.
Among these is the 2001 Crystal Matula Award from the European Association of Urology, an award recognising promising young urologists and their contributions to the specialty.
His professional distinctions also include the Felix Guillon Award of the French Association of Urology and honorary academic appointments at several European universities.
Throughout his career, he has participated in international urological organisations, scientific committees and educational programmes, contributing to the development and exchange of specialist medical knowledge.
